Nan Fung Group Holdings Ltd TRDA ENTRADA THERAPEUTICS INC

Ownership history in Nan Fung Group Holdings Ltd  ·  17 quarters on record

AI Ownership Summary

Nan Fung Group Holdings Ltd reported ENTRADA THERAPEUTICS INC (TRDA) in 17 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 0.75% in 2024 Q2. The latest visible filing shows TRDA at 0.51% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this TRDA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Nan Fung Group Holdings Ltd's position in ENTRADA THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

TRDA was reported at 0.51% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.75% in 2024 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Nan Fung Group Holdings Ltd held TRDA — position size vs. price
% of Fund (quarterly)    TRDA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED 49,082 0% 0.51% $619K 2026-05-14 $6.83
2025 Q4 UNCHANGED 49,082 0% 0.45% $505K 2026-02-13 $10.88
2025 Q3 UNCHANGED 49,082 0% 0.48% $285K 2025-11-13 $8.78
2025 Q2 UNCHANGED 49,082 0% 0.52% $330K 2025-08-13 $5.32
2025 Q1 UNCHANGED 49,082 0% 0.36% $444K 2025-05-14 $7.97
2024 Q4 UNCHANGED 49,082 0% 0.73% $849K 2025-02-13 $12.63
2024 Q3 UNCHANGED 49,082 0% 0.68% $784K 2024-11-13 $19.96
2024 Q2 UNCHANGED 49,082 0% 0.75% $699K 2024-08-13 $15.81
2024 Q1 UNCHANGED 49,082 0% 0.64% $695K 2024-05-14 $14.19
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Nan Fung Group Holdings Ltd and TRDA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Nan Fung Group Holdings Ltd reported owning TRDA?

Nan Fung Group Holdings Ltd reported TRDA across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported TRDA position in Nan Fung Group Holdings Ltd's portfolio?

The largest reported portfolio weight for TRDA was 0.75% in 2024 Q2.

What is the latest reported TRDA position on this page?

The most recent filing on this page is 2026 Q1, when Nan Fung Group Holdings Ltd reported 49,082 shares, equal to 0.51% of portfolio, with an estimated market value of $619K.

What does the chart on this TRDA ownership page compare?

The chart compares Nan Fung Group Holdings Ltd's quarterly TRDA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Nan Fung Group Holdings Ltd time their TRDA position?

Based on 13F filing dates vs. subsequent TRDA price moves, Nan Fung Group Holdings Ltd correctly timed 4 out of 4 reported position changes (100%). The annualised alpha on TRDA relative to SPY over the holding period was -12.6%.

← Back to Nan Fung Group Holdings Ltd Holdings